New antibiotic studied in kids: how does the body handle it?

NCT ID NCT05217537

Completed Knowledge-focused Sponsor: Paratek Pharmaceuticals Inc Source: ClinicalTrials.gov ↗

First seen Mar 19, 2026 · Last updated Apr 23, 2026 · Updated 4 times

Summary

This early-phase study looked at how a single dose of the antibiotic omadacycline is processed in the bodies of 23 children and teens (ages 8 to 17) with bacterial infections. Participants received the drug either by IV or by mouth. The main goal was to measure drug levels in the blood and check for side effects, not to treat the infection directly. The study is complete and helps guide future dosing in children.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Site 105

Chicago, Illinois, 60611, United States
Site 106

Cleveland, Ohio, 60611, United States
Site 107

Orange, California, 92868, United States
Site 108

Houston, Texas, 77030, United States
Site 109

Little Rock, Arkansas, 72202, United States
Site 111

Greenville, North Carolina, 27858, United States
Site 112

Long Beach, California, 90806, United States
Site 113

Philadelphia, Pennsylvania, 19104, United States
Site 114

Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.

BACTERIAL INFECTIONS